The board will examine a proposal for investment in Biocon Biologics Ltd (BBL) through the purchase or acquisition of securities from existing shareholders of BBL. The consideration may involve cash and/or non-cash components. Shares of Biocon Ltd ended at ₹410.15, down by ₹10.00, or 2.50%, on the BSE.
